Overexpression of FUS1/TUSC2 down-regulates mTOR signaling, which stimulates PD-L1, an immunosuppressive ligand up-regulated in many types of tumors including NSCLC. This evidence concerns the gene MTOR and non-small cell lung carcinoma.